Changing the face of surgical oncology and lighting the way to a cancer-free future.

Dr. Drew welcomes surgical oncologist Dr. Fedra Fallahian and Lumicell’s Chief Scientific Officer, Dr. Jorge Ferrer, to discuss the limitations of traditional breast cancer surgery and the revolutionary impact of the LumiSystem. The segment addresses the critical challenge surgeons face when they cannot see the “enemy” they are fighting, often leading to positive margins and the need for follow-up procedures. Viewers will learn about the science behind Lumicell—a unique combination of a fluorescent drug and a handheld imaging device—which allows surgeons to look directly inside the breast cavity to identify and remove lingering cancer cells in real-time. The profile further delves into the personal origins of the company, tracing its journey from MIT to clinical commercialization, inspired by the founder’s own family experience with cancer. Dr. Drew and his guests examine the practical benefits of the system, including its minimal impact on surgical time and its proven effectiveness in clinical trials. The segment also features a powerful patient perspective, illustrating how this transformative technology provides peace of mind and improves surgical outcomes for women facing breast cancer surgery.